Xconomy National

by in

Entry	Author	Date	Location
Cadence Faces Competition from Generic Pain Reliever, Less Than a Year After FDA Approval	Luke Timmerman	06/30/11	San Diego
Somaxon Fighting Fresh Challenge from Generic Drug-Makers	Bruce V. Bigelow	06/01/11	San Diego
FDA Gives Nod to Momenta’s Anti-Clotting Generic, Ingenix Acquires Picis, Millennium Harnesses BioScale’s Protein-Measuring Technology, & More Boston-Area Life Sciences News	Erin Kutz	07/30/10	Boston
Teva Takes Aim at Cubist Pharma’s Key Antibiotic Business	Ryan McBride	02/10/09	Boston
Momenta Raises $24.1M From Select Investors	Luke Timmerman	12/12/08	Boston
Momenta Gets Some Mojo As FDA Agrees To Review Application of Generic MS Drug	Luke Timmerman	07/11/08	Boston
Page 1 of 1